These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 32789350

  • 21. Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer.
    Ma S, Li X, Ran M, Ji M, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X.
    Int J Pharm; 2021 May 15; 601():120577. PubMed ID: 33839227
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L, Beale P, Yu JQ, Proschogo N, Huq F.
    Anticancer Res; 2014 Dec 15; 34(12):7077-90. PubMed ID: 25503135
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 32. The Application of Biomaterials in the Treatment of Platinum-Resistant Ovarian Cancer.
    Levy A, Leynes C, Baig M, Chew SA.
    ChemMedChem; 2019 Nov 06; 14(21):1810-1827. PubMed ID: 31456347
    [Abstract] [Full Text] [Related]

  • 33. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
    Wang L, Liu Z, He S, He S, Wang Y.
    J Mater Chem B; 2021 Jun 02; 9(22):4587-4595. PubMed ID: 34059856
    [Abstract] [Full Text] [Related]

  • 34. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
    Sun X, Lou LG, Sui DH, Wu XH.
    Asian Pac J Cancer Prev; 2014 Jun 02; 15(22):9939-43. PubMed ID: 25520132
    [Abstract] [Full Text] [Related]

  • 35. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q, Yang Y, Lin X, Ma W, Chen G, Li W, Wang X, Yu Z.
    Chem Commun (Camb); 2018 May 22; 54(42):5369-5372. PubMed ID: 29744485
    [Abstract] [Full Text] [Related]

  • 36. Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).
    Al-Shuneigat J, Qing Y, Beale P, Fisher K, Huq F.
    Med Chem; 2011 Jan 22; 7(1):1-8. PubMed ID: 21235513
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.